1. Home
  2. IZEA vs ANL Comparison

IZEA vs ANL Comparison

Compare IZEA & ANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IZEA Worldwide Inc.

IZEA

IZEA Worldwide Inc.

HOLD

Current Price

$5.01

Market Cap

69.1M

ML Signal

HOLD

Logo Adlai Nortye Ltd.

ANL

Adlai Nortye Ltd.

HOLD

Current Price

$1.28

Market Cap

52.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
IZEA
ANL
Founded
2006
2004
Country
United States
Cayman Islands
Employees
N/A
N/A
Industry
Advertising
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
69.1M
52.0M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
IZEA
ANL
Price
$5.01
$1.28
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
154.7K
25.3K
Earning Date
11-12-2025
04-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$36,176,492.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$15.91
N/A
P/E Ratio
N/A
N/A
Revenue Growth
7.12
N/A
52 Week Low
$1.68
$0.88
52 Week High
$5.86
$2.99

Technical Indicators

Market Signals
Indicator
IZEA
ANL
Relative Strength Index (RSI) 52.00 46.80
Support Level $4.86 $0.88
Resistance Level $5.07 $1.59
Average True Range (ATR) 0.20 0.18
MACD -0.01 -0.01
Stochastic Oscillator 64.71 57.83

Price Performance

Historical Comparison
IZEA
ANL

About IZEA IZEA Worldwide Inc.

IZEA Worldwide Inc offers solutions that range from creator agency services to creator technologies to a marketplace that connects marketers with creators. The Company provides value through managing custom content workflow, creator search and targeting, bidding, analytics, and payment processing. The company also enables creators to monetize their content, creativity, and influence through brands and marketers. The company compensates these creators for producing content, such as long and short-form text, videos, photos, status updates, and illustrations, for marketers or distributing such content on behalf of marketers through their websites, blogs, and social media channels.

About ANL Adlai Nortye Ltd.

Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.

Share on Social Networks: